🇺🇸 FDA
Patent

US 7544358

Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6

granted A61KA61K38/39A61P

Quick answer

US patent 7544358 (Treatment of acute lung injury, fibrosis and metastasis with antagonists of αvβ6) held by The Regents of the University of California expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K38/39, A61P, A61P1/16, A61P11/00